10 initially the suspension was for a period of six months commencing on 28 april 2003 but subsequently further notices were given under the therapeutic goods act for suspension and product recalls.
32 the court's power to give directions pursuant to s 511 is subject to the provisions of s 511(2).
i acceded to that application.